These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatobiliary scintigraphy and function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTC-PMT). Sugimura K; Nishiyama S; Narabayashi I Kobe J Med Sci; 1985 Apr; 31(2):85-94. PubMed ID: 4021432 [No Abstract] [Full Text] [Related]
3. [Clinical efficacy of hepatobiliary scintigraphy using 99m Tc-N-pyridoxyl-5-methyltryptophan (PMT)]. Aburano T; Ohguchi M; Kuwajima A; Tonami N; Hisada K Kaku Igaku; 1983 Apr; 20(3):353-60. PubMed ID: 6632363 [No Abstract] [Full Text] [Related]
4. Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging. Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Noguchi A; Sasaki Y; Imaoka S; Fujita M; Kawamoto S; Kasugai H Cancer; 1986 Jan; 57(2):230-6. PubMed ID: 2417674 [TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of the hepatobiliary scintigraphy using 99mTc-N-pyridoxyl-5-methyl tryptophan (99mTc-PMT)]. Kuwabara Y; Oshiumi Y; Ichiya Y; Wada M; Shiozaki H; Hirata N; Matsuura K Radioisotopes; 1983 Jan; 32(1):26-9. PubMed ID: 6856881 [No Abstract] [Full Text] [Related]
6. [Experimental and clinical studies of hepatobiliary scintigraphy using 99mTc-N-pyridoxyl-5-methyltryptophan(99mTc-PMT)]. Yoshida H; Kanamori I; Nakano S; Takeda I; Yasuda E; Matsuo S; Ichikawa H; Kimura T; Iwata F; Higuchi C Radioisotopes; 1983 Jul; 32(7):340-43. PubMed ID: 6658021 [No Abstract] [Full Text] [Related]
7. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent. Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618 [TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of 99mTc-(Sn)-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in diagnosis of hepatoma]. Hasegawa Y; Nakano S; Noguchi A; Hashizume T; Ibuka K; Sasaki Y; Imaoka M; Kozima J; Ishigami S Kaku Igaku; 1983 Nov; 20(9):1355-9. PubMed ID: 6328071 [No Abstract] [Full Text] [Related]
9. [The influence of ursodeoxycholic acid on hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan in chronic liver diseases]. Hayakawa T; Katagiri K; Shiraka S; Nakai T; Takeshima A; Kawamura Y; Ohnishi H; Hoshino M; Tsukada K; Miyani M Nihon Shokakibyo Gakkai Zasshi; 1988 Nov; 85(11):2389-95. PubMed ID: 3221493 [No Abstract] [Full Text] [Related]
10. [Hepatobiliary scintigraphy and liver function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT)]. Sugimura K; Narabayashi I; Nabeshima K; Ishido N; Hashimoto K; Yamasaki K; Hamada T; Sugimura C; Suematsu T; Inoue Y Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Oct; 43(10):1205-13. PubMed ID: 6672750 [No Abstract] [Full Text] [Related]
11. Clinical evaluation on hepatobiliary scintigraphy with 99mTc(Sn)-N-pyridoxyl-5-methyltryptophan. Yamashita M; Watanabe A; Miyazaki T; Nakajima E; Okuno T Radioisotopes; 1982 Dec; 31(12):657-9. PubMed ID: 7170355 [No Abstract] [Full Text] [Related]
12. [Basic and clinical evaluation of hepatobiliary function by 99mTc-pyridoxyl-5-methyl-tryptophan]. Morimoto Y; Tochio H; Yamada A; Hamasaki T; Saiki Y; Bito S; Ito H; Ikekubo K; Senda M; Kudo M Kaku Igaku; 1983 Nov; 20(9):1361-9. PubMed ID: 6676522 [No Abstract] [Full Text] [Related]
13. Clinical significance of 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in the diagnosis of intrahepatic masses. Oyamada H; Yamazaki S; Makuuchi M; Hasegawa H Radioisotopes; 1989 May; 38(5):244-51. PubMed ID: 2546192 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of acute cholecystitis using hepatobiliary scintigraphy with 99mTc-PMT]. Takada T; Yasuda H; Uchiyama K; Hasegawa H; Shikata J; Kuniyasu Y; Higashi S Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Jul; 45(7):1032-8. PubMed ID: 4080522 [No Abstract] [Full Text] [Related]
15. Comparison of delayed hepatobiliary imaging using 99mTc-Sn-N-pyridoxyl-5-methyltryptophan and 67Ga-citrate imaging for diagnosis of hepatocellular carcinoma. Hasegawa Y; Nakano S; Ishiguro S; Imaoka S; Sasaki Y; Tanaka S; Kasugai H; Kojima J; Ishigami S Eur J Nucl Med; 1988; 14(7-8):414-8. PubMed ID: 2846309 [TBL] [Abstract][Full Text] [Related]
16. [Studies on the clinical usefulness of 99mTc-N-Pyridoxyl-5-methyltryptophan as a hepatobiliary scintigraphic agent]. Watanabe Y; Sugimoto S; Kobori K; Katsuyama N; Zeniya M; Kawakami K Kaku Igaku; 1982 Dec; 19(10):1589-93. PubMed ID: 7169693 [No Abstract] [Full Text] [Related]
17. Relationship of uptake of technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis. Hasegawa Y; Nakano S; Hiyama T; Sobue T; Yoshida H; Sasaki Y; Imaoka S; Inoue A; Tanaka S; Kusagai H J Nucl Med; 1991 Feb; 32(2):228-35. PubMed ID: 1846910 [TBL] [Abstract][Full Text] [Related]
18. [Usefulness of 99mTc-PMT cholescintigraphy in diagnosis a case of bone metastasis in hepatocellular carcinoma]. Inoue A; Imaeda T; Yanagawa S; Doi T Rinsho Hoshasen; 1989 Aug; 34(8):901-2. PubMed ID: 2555595 [No Abstract] [Full Text] [Related]
19. Comparison of 99mTc-N-pyridoxyl-5-methyltryptophan and 99mTc-N-(3-bromo-2,4,6-trimethylacetanilide)-iminodiace tate as hepatobiliary radiopharmaceuticals in rats. Fritzberg AR; Bloedow DC; Eshima D; Johnson DL J Pharm Sci; 1984 Dec; 73(12):1861-3. PubMed ID: 6527280 [TBL] [Abstract][Full Text] [Related]
20. [Scintigraphy using 99mTc-PMT, 99mTc-DEIDA, or 67Ga--detection of hepatocellular carcinoma and its metastasis]. Hasegawa Y; Nakano S Nihon Rinsho; 1991 Aug; 49(8):1858-62. PubMed ID: 1664892 [No Abstract] [Full Text] [Related] [Next] [New Search]